Annual ROE
-1766.94%
-1655.86%-1490.69%
December 31, 2023
Summary
- As of February 7, 2025, BTAI annual return on equity is -1766.94%, with the most recent change of -1655.86% (-1490.69%) on December 31, 2023.
- During the last 3 years, BTAI annual ROE has fallen by -1727.19% (-4345.13%).
- BTAI annual ROE is now -370.04% below its all-time high of 654.32%, reached on December 31, 2016.
Performance
BTAI ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
98.33%
-78.60%-44.42%
September 30, 2024
Summary
- As of February 7, 2025, BTAI quarterly return on equity is 98.33%, with the most recent change of -78.60% (-44.42%) on September 30, 2024.
- Over the past year, BTAI quarterly ROE has increased by +2422.00% (+104.23%).
- BTAI quarterly ROE is now -78.73% below its all-time high of 462.22%, reached on December 31, 2017.
Performance
BTAI Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
BTAI ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1490.7% | +104.2% |
| 3 y3 years | -4345.1% | +318.7% |
| 5 y5 years | -3466.0% | +201.3% |
BTAI ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3562.8% | at low | -73.7% | +104.2% |
| 5 y | 5-year | -4345.1% | at low | -73.7% | +104.2% |
| alltime | all time | -370.0% | at low | -78.7% | +104.2% |
BioXcel Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 98.33%(-44.4%) |
| Jun 2024 | - | 176.93%(-52.7%) |
| Mar 2024 | - | 374.17%(-116.1%) |
| Dec 2023 | -1766.94%(+1490.7%) | -2323.67%(+387.6%) |
| Sep 2023 | - | -476.54%(+100.5%) |
| Jun 2023 | - | -237.68%(+33.7%) |
| Mar 2023 | - | -177.74%(+50.7%) |
| Dec 2022 | -111.08%(+130.3%) | -117.97%(+52.1%) |
| Sep 2022 | - | -77.56%(+31.1%) |
| Jun 2022 | - | -59.15%(+22.6%) |
| Mar 2022 | - | -48.25%(+3.9%) |
| Dec 2021 | -48.24% | -46.42%(+3.2%) |
| Sep 2021 | - | -44.97%(-0.7%) |
| Jun 2021 | - | -45.29%(-19.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | -56.09%(-5.5%) |
| Dec 2020 | -39.75%(-67.6%) | -59.37%(-20.0%) |
| Sep 2020 | - | -74.22%(-35.2%) |
| Jun 2020 | - | -114.52%(+12.0%) |
| Mar 2020 | - | -102.29%(-7.8%) |
| Dec 2019 | -122.58%(+147.4%) | -110.97%(+14.3%) |
| Sep 2019 | - | -97.12%(+25.0%) |
| Jun 2019 | - | -77.72%(+46.1%) |
| Mar 2019 | - | -53.19%(+28.8%) |
| Dec 2018 | -49.55%(-110.7%) | -41.30%(+2.9%) |
| Sep 2018 | - | -40.13%(+25.6%) |
| Jun 2018 | - | -31.96%(-1.5%) |
| Mar 2018 | - | -32.44%(-107.0%) |
| Dec 2017 | 462.22%(-29.4%) | 462.22% |
| Dec 2016 | 654.32% | - |
FAQ
- What is BioXcel Therapeutics annual return on equity?
- What is the all time high annual ROE for BioXcel Therapeutics?
- What is BioXcel Therapeutics annual ROE year-on-year change?
- What is BioXcel Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for BioXcel Therapeutics?
- What is BioXcel Therapeutics quarterly ROE year-on-year change?
What is BioXcel Therapeutics annual return on equity?
The current annual ROE of BTAI is -1766.94%
What is the all time high annual ROE for BioXcel Therapeutics?
BioXcel Therapeutics all-time high annual return on equity is 654.32%
What is BioXcel Therapeutics annual ROE year-on-year change?
Over the past year, BTAI annual return on equity has changed by -1655.86% (-1490.69%)
What is BioXcel Therapeutics quarterly return on equity?
The current quarterly ROE of BTAI is 98.33%
What is the all time high quarterly ROE for BioXcel Therapeutics?
BioXcel Therapeutics all-time high quarterly return on equity is 462.22%
What is BioXcel Therapeutics quarterly ROE year-on-year change?
Over the past year, BTAI quarterly return on equity has changed by +2422.00% (+104.23%)